The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2013
Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for transient tachypnea of newborn: a randomized, prospective study.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Demirel Gamze, Uras Nurdan, Celik Istemi Han, Canpolat Fuat Emre, Dilmen Ugur
Аннотация
OBJECTIVE: To evaluate the efficacy of nasal intermittent mandatory ventilation (NIMV) in reducing the duration of respiratory distress compared with nasal continuous positive airway pressure (NCPAP) in transient tachypnea of the newborn (TTN).
PATIENT AND METHODS: In this randomized-prospective study, 40 infants with a gestational age ≥ 37 weeks and birth weight ≥ 2000 g with TTN were randomized to either nonsynchronized NIMV (n = 20) or NCPAP (n = 20). The primary end point was the reduction of the duration of respiratory distress. Secondary end points were the duration and level of oxygen supplementation, the incidence of complications such as pneumothorax, pneumonia and respiratory failure requiring entubation.
RESULTS: There were no significant difference in the duration of respiratory support (28.0 ± 19.2 h versus 32.2 ± 23.3 h, p = 0.231), O2 therapy (31.2 ± 15.6 h versus 29.0 ± 19.3 h, p = 0.187), duration of TTN (67.6 ± 36.5 h versus 63.3 ± 39.1 h, p = 0.480) and hospitalization (6.2 ± 2.6 d versus 5.4 ± 2.0 d, p = 0.330) between the groups. The rate of complications were not significantly different between the groups.
CONCLUSION: Our study indicates that NIMV is well tolerated and as effective as NCPAP in the treatment of TTN.
PATIENT AND METHODS: In this randomized-prospective study, 40 infants with a gestational age ≥ 37 weeks and birth weight ≥ 2000 g with TTN were randomized to either nonsynchronized NIMV (n = 20) or NCPAP (n = 20). The primary end point was the reduction of the duration of respiratory distress. Secondary end points were the duration and level of oxygen supplementation, the incidence of complications such as pneumothorax, pneumonia and respiratory failure requiring entubation.
RESULTS: There were no significant difference in the duration of respiratory support (28.0 ± 19.2 h versus 32.2 ± 23.3 h, p = 0.231), O2 therapy (31.2 ± 15.6 h versus 29.0 ± 19.3 h, p = 0.187), duration of TTN (67.6 ± 36.5 h versus 63.3 ± 39.1 h, p = 0.480) and hospitalization (6.2 ± 2.6 d versus 5.4 ± 2.0 d, p = 0.330) between the groups. The rate of complications were not significantly different between the groups.
CONCLUSION: Our study indicates that NIMV is well tolerated and as effective as NCPAP in the treatment of TTN.